Toxicity and Efficacy Probability Interval Design for Phase I Adoptive Cell Therapy Dose-Finding Clinical Trials

DOI10.1158/1078-0432.CCR-16-1125WikidataQ50039167 ScholiaQ50039167MaRDI QIDQ100708

Wentian Guo, Yuan Ji, James B. Whitmore, Daniel H. Li

Publication date: 1 January 2017

Published in: Clinical Cancer Research (Search for Journal in Brave)

Related Items (1)

Keyboard

This page was built for publication: Toxicity and Efficacy Probability Interval Design for Phase I Adoptive Cell Therapy Dose-Finding Clinical Trials

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q100708)